Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Reflexology massage helps hair regrowth in women after chemotherapy.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

Developing microRNA-based treatments is hard but has potential.

Afatinib often causes skin problems that need proactive management.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.